These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17968739)

  • 1. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects.
    Webborn PJ; Parker AJ; Denton RL; Riley RJ
    Xenobiotica; 2007; 37(10-11):1090-109. PubMed ID: 17968738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
    Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics.
    Iwatsubo T; Hirota N; Ooie T; Suzuki H; Sugiyama Y
    Biopharm Drug Dispos; 1996 May; 17(4):273-310. PubMed ID: 8845471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
    Yabe Y; Galetin A; Houston JB
    Drug Metab Dispos; 2011 Oct; 39(10):1808-14. PubMed ID: 21730030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin.
    Treijtel N; van Helvoort H; Barendregt A; Blaauboer BJ; van Eijkeren JC
    Drug Metab Dispos; 2005 Sep; 33(9):1325-32. PubMed ID: 15951450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological principles of imipramine pharmacokinetics].
    Szymura-Oleksiak J
    Folia Med Cracov; 1989; 30(3-4):103-21. PubMed ID: 2641936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological pharmacokinetic modelling.
    Balant LP; Gex-Fabry M
    Xenobiotica; 1990 Nov; 20(11):1241-57. PubMed ID: 2275217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-mediated hepatic uptake of rose bengal in analbuminemic mutant rats (NAR). Albumin is not indispensable to the protein-mediated transport of rose bengal.
    Tsao SC; Sugiyama Y; Shinmura K; Sawada Y; Nagase S; Iga T; Hanano M
    Drug Metab Dispos; 1988; 16(3):482-9. PubMed ID: 2457477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
    Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transport.
    Sjögren E; Bredberg U; Lennernäs H
    Mol Pharm; 2012 Apr; 9(4):823-41. PubMed ID: 22352317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.